The Food and Drug Administration will determine whether naloxone devices distributed in communities should contain a standard dose of the opioid overdose antidote, according to U.S. News & World Report.
Attorneys general from 35 states and the District of Columbia are suing a British drug company, alleging it tried to keep less expensive generic versions of the opioid addiction treatment Suboxone off the market.
Most patients taking opioid painkillers are willing to fill a prescription for the opioid overdose antidote naloxone, a new small study suggests. Prescribing naloxone to patients taking opioid painkillers is increasingly recommended by medical guidelines, HealthDay reports.
The American Academy of Pediatrics is recommending that pediatricians consider offering medication-assisted treatment, such as buprenorphine, for teen and young adult patients with severe opioid use disorders, USA Today reports.
Many insurance companies require patients who have been prescribed the opioid addiction treatment Suboxone to get prior authorization, NPR reports. This requirement can take days or weeks, leaving patients vulnerable to relapse, one expert says.